Anti-IBP5/ IGFBP5 functional antibody

Anti-IBP5/ IGFBP5 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IGFBP5/IGFBP5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0987-Ab-1/ GM-Tg-hg-SE0987-Ab-2Anti-Human IGFBP5 monoclonal antibodyHuman
GM-Tg-rg-SE0987-Ab-1/ GM-Tg-rg-SE0987-Ab-2Anti-Rat IGFBP5 monoclonal antibodyRat
GM-Tg-mg-SE0987-Ab-1/ GM-Tg-mg-SE0987-Ab-2Anti-Mouse IGFBP5 monoclonal antibodyMouse
GM-Tg-cynog-SE0987-Ab-1/ GM-Tg-cynog-SE0987-Ab-2Anti-Cynomolgus/ Rhesus macaque IGFBP5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0987-Ab-1/ GM-Tg-felg-SE0987-Ab-2Anti-Feline IGFBP5 monoclonal antibodyFeline
GM-Tg-cang-SE0987-Ab-1/ GM-Tg-cang-SE0987-Ab-2Anti-Canine IGFBP5 monoclonal antibodyCanine
GM-Tg-bovg-SE0987-Ab-1/ GM-Tg-bovg-SE0987-Ab-2Anti-Bovine IGFBP5 monoclonal antibodyBovine
GM-Tg-equg-SE0987-Ab-1/ GM-Tg-equg-SE0987-Ab-2Anti-Equine IGFBP5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0987-Ab-1/ GM-Tg-hg-SE0987-Ab-2; GM-Tg-rg-SE0987-Ab-1/ GM-Tg-rg-SE0987-Ab-2;
GM-Tg-mg-SE0987-Ab-1/ GM-Tg-mg-SE0987-Ab-2; GM-Tg-cynog-SE0987-Ab-1/ GM-Tg-cynog-SE0987-Ab-2;
GM-Tg-felg-SE0987-Ab-1/ GM-Tg-felg-SE0987-Ab-2; GM-Tg-cang-SE0987-Ab-1/ GM-Tg-cang-SE0987-Ab-2;
GM-Tg-bovg-SE0987-Ab-1/ GM-Tg-bovg-SE0987-Ab-2; GM-Tg-equg-SE0987-Ab-1/ GM-Tg-equg-SE0987-Ab-2
Products NameAnti-IGFBP5 monoclonal antibody
Formatmab
Target NameIGFBP5
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IGFBP5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0987-Ag-1Recombinant multi-species IBP5/ IGFBP5 protein
    CytokineGM-Tg-g-SE0987-Ag-1insulin-like growth factor binding protein 5 (IGFBP5) protein
    ORF Viral VectorvGMLP000569human IGFBP5 Lentivirus particle
    ORF Viral VectorpGMLP000569human IGFBP5 Lentivirus plasmid
    ORF Viral VectorpGMLPm000393mouse Igfbp5 Lentivirus plasmid
    ORF Viral VectorvGMLPm000393mouse Igfbp5 Lentivirus particle


    Target information

    Target IDGM-SE0987
    Target NameIGFBP5
    Gene ID3488,16011,25285,696339,610316,101084305,404185,100034063
    Gene Symbol and SynonymsIBP5,IGF-BP5,IGFBP-5,IGFBP-5P,IGFBP5
    Uniprot AccessionP24593,P24594,Q05717
    Uniprot Entry NameIBP5_HUMAN,IBP5_RAT,IBP5_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseBreast Cancer, Dent disease
    Gene EnsemblENSG00000115461
    Target ClassificationN/A

    The target: IGFBP5, gene name: IGFBP5, also named as IBP5. Enables insulin-like growth factor I binding activity. Involved in several processes, including cellular response to cAMP; regulation of smooth muscle cell migration; and regulation of smooth muscle cell proliferation. Part of insulin-like growth factor ternary complex. Biomarker of pulmonary fibrosis. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.